Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?
Top Cited Papers
Open Access
- 1 May 2010
- journal article
- review article
- Published by American Diabetes Association in Diabetes
- Vol. 59 (5), 1117-1125
- https://doi.org/10.2337/db09-1899
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Four weeks of near‐normalization of blood glucose has no effect on postprandial GLP‐1 and GIP secretion, but augments pancreatic B‐cell responsiveness to a meal in patients with Type 2 diabetesDiabetic Medicine, 2008
- Is secretion of glucagon-like peptide-1 reduced in type 2 diabetes mellitus?Nature Clinical Practice Endocrinology & Metabolism, 2008
- Effects of beta-cell rest on beta-cell function: a review of clinical and preclinical dataPediatric Diabetes, 2008
- Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphismsDiabetologia, 2007
- A novel pathway for regulation of glucose‐dependent insulinotropic polypeptide receptor expression in β‐cellsThe FASEB Journal, 2002
- The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin SensitivityEndocrine Reviews, 1998
- Safety and Efficacy of Normalizing Fasting Glucose With Bedtime NPH Insulin Alone in NIDDMDiabetes Care, 1995
- Islet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus RevisitedPathology and Immunopathology Research, 1985
- The incretin concept todayDiabetologia, 1979
- Beta-cell function improved by supplementing basal insulin secretion in mild diabetes.BMJ, 1976